These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol. Bojnik E; Babos F; Fischetti C; Magyar A; Camarda V; Borsodi A; Bajusz S; Calo' G; Benyhe S Brain Res Bull; 2010 Mar; 81(4-5):477-83. PubMed ID: 19800951 [TBL] [Abstract][Full Text] [Related]
7. In vitro characterization of Ac-RYYRWK-NH(2), Ac-RYYRIK-NH(2) and [Phe1Psi(CH(2)-NH)Gly2] nociceptin(1-13)NH(2) at rat native and recombinant ORL(1) receptors. Mason SL; Ho M; Nicholson J; McKnight AT Neuropeptides; 2001; 35(5-6):244-56. PubMed ID: 12030809 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity studies on high affinity NOP-active hexapeptides. Judd AK; Tuttle DJ; Jones RW; Sanchez A; Polgar W; Berzetei-Gurske I; Toll L J Pept Res; 2004 Sep; 64(3):87-94. PubMed ID: 15317498 [TBL] [Abstract][Full Text] [Related]
9. In vitro binding and functional studies of Ac-RYYRIK-ol and its derivatives, novel partial agonists of the nociceptin/orphanin F/Q receptor. Gunduz O; Sipos F; Spagnolo B; Kocsis L; Magyar A; Orosz G; Borsodi A; Calò G; Benyhe S Neurosignals; 2006-2007; 15(2):91-101. PubMed ID: 16874009 [TBL] [Abstract][Full Text] [Related]
10. Opioid receptor-like 1 (ORL1) receptor binding and the biological properties of Ac-Arg-Tyr-Tyr-Arg-Ile-Arg-NH2 and its analogs. Ambo A; Kohara H; Kawano S; Sasaki Y J Pept Sci; 2007 Oct; 13(10):672-8. PubMed ID: 17712865 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol. Gündüz O; Rizzi A; Baldisserotto A; Guerrini R; Spagnolo B; Gavioli EC; Kocsis L; Magyar A; Benyhe S; Borsodi A; Calò G Eur J Pharmacol; 2006 Jun; 539(1-2):39-48. PubMed ID: 16682024 [TBL] [Abstract][Full Text] [Related]
12. [3H]ac-RYYRWK-NH2, a novel specific radioligand for the nociceptin/orphanin FQ receptor. Thomsen C; Valsborg JS; Platou J; Martin J; Foged C; Johansen NL; Olsen UB; Madsen K Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):538-45. PubMed ID: 11138846 [TBL] [Abstract][Full Text] [Related]
13. Effects of nociceptin and endomorphin 1 on the electrically stimulated human vas deferens. Bigoni R; Calo G; Guerrini R; Strupish JW; Rowbotham DJ; Lambert DG Br J Clin Pharmacol; 2001 Apr; 51(4):355-8. PubMed ID: 11318773 [TBL] [Abstract][Full Text] [Related]
14. In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors. Bigoni R; Rizzi A; Rizzi D; Becker JA; Kieffer BL; Simonin F; Regoli D; Calo G Life Sci; 2000 Dec; 68(2):233-9. PubMed ID: 11191640 [TBL] [Abstract][Full Text] [Related]
15. Nociceptin antagonism: probing the receptor by N-acetyl oligopeptides. Kocsis L; Orosz G; Magyar A; Al-Khrasani M; Kató E; Rónai AZ; Bes B; Meunier JC; Gündüz O; Tóth G; Borsodi A; Benyhe S Regul Pept; 2004 Nov; 122(3):199-207. PubMed ID: 15491792 [TBL] [Abstract][Full Text] [Related]
16. Biochemical and pharmacological investigation of novel nociceptin/OFQ analogues and N/OFQ-RYYRIK hybrid peptides. Erdei AI; Borbély A; Magyar A; Szűcs E; Ötvös F; Gombos D; Al-Khrasani M; Stefanucci A; Dimmito MP; Luisi G; Mollica A; Benyhe S Peptides; 2019 Feb; 112():106-113. PubMed ID: 30513351 [TBL] [Abstract][Full Text] [Related]
17. Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1. Dooley CT; Spaeth CG; Berzetei-Gurske IP; Craymer K; Adapa ID; Brandt SR; Houghten RA; Toll L J Pharmacol Exp Ther; 1997 Nov; 283(2):735-41. PubMed ID: 9353393 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity of new series of N-modified analogues of the N/OFQ(1-13)NH2 with aminophosphonate moiety. Todorov PT; Mateeva PI; Zamfirova RN; Pavlov ND; Naydenova ED Amino Acids; 2012 Sep; 43(3):1217-23. PubMed ID: 22143428 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of small peptides as NOP and opioid receptors' ligands: view on current developments. Naydenova E; Todorov P; Zamfirova R Vitam Horm; 2015; 97():123-46. PubMed ID: 25677770 [TBL] [Abstract][Full Text] [Related]
20. A structure-activity study of nociceptin-(1-13)-peptide amide. Synthesis of analogues substituted in positions 0, 1, 3, 4 and 10. Bobrova I; Vlaskovska M; Kasakov L; Surovoy A; Egorova N; Johansson L; Karsnas P; Terenius L Eur J Med Chem; 2003; 38(7-8):687-94. PubMed ID: 12932899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]